Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers
Poklepovic A, Qu Y, Dickinson M et al.
KEYWORDS
Anthracycline; Biomarker; Cardioprotection; Chemotherapy; Clinical trial; Doxorubicin; Ejection fraction; Strain